Polyvalent prophylactic vaccine (MabVaxr)
多价预防性疫苗（MabVax）
Report date: 2022/01/14 13:23:58
Base Information
Drug NamePolyvalent prophylactic vaccine (MabVaxr)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesMabvax Therapeutics IncMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A